4.6 Article

Probiotic Bacteria Induce Maturation of Intestinal Claudin 3 Expression and Barrier Function

Journal

AMERICAN JOURNAL OF PATHOLOGY
Volume 180, Issue 2, Pages 626-635

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2011.10.025

Keywords

-

Categories

Funding

  1. NIH [DK007771, R01 HD059142, HD059142-01S1, R01 DK 059888, R01 HD059122]
  2. Emory Digestive Diseases Research Development Center [R24 DK064399]

Ask authors/readers for more resources

An immature intestinal epithelial barrier may predispose infants and children to many intestinal inflammatory diseases, such as infectious enteritis, inflammatory bowel disease, and necrotizing enterocolitis. Understanding the factors that regulate gut barrier maturation may yield insight into strategies to prevent these intestinal diseases. The claudin family of tight junction proteins plays an important role in regulating epithelial paracellular permeability. Previous reports demonstrate that rodent intestinal barrier function matures during the first 3 weeks of life. We show that murine paracellular permeability markedly decreases during postnatal maturation, with the most significant change occurring between 2 and 3 weeks. Here we report for the first time that commensal bacterial colonization induces intestinal barrier function maturation by promoting claudin 3 expression. Neonatal mice raised on antibiotics or lacking the toll-like receptor adaptor protein MyD88 exhibit impaired barrier function and decreased claudin 3 expression. Furthermore, enteral administration of either live or heat-killed preparations of the probiotic Lactobacillus rhamnosus GG accelerates intestinal barrier maturation and induces claudin 3 expression. However, live Lactobacillus rhamnosus GG increases mortality. Taken together, these results support a vital role for intestinal flora in the maturation of intestinal barrier function. Probiotics may prevent intestinal inflammatory diseases by regulating intestinal tight junction protein expression and barrier function. The use of heat-killed probiotics may provide therapeutic benefit while minimizing adverse effects. (Am J Pathol 2012, 180:626-635; DOI: 10.1016/j.ajpath.2011.10.025)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available